Fig. 3.
Fig. 3. Six-year relapse probability after HSCT for children affected by hematologic malignancies, according to cGVHD development. / Patients experiencing cGVHD had a significantly lower risk of relapse (P = .0001).

Six-year relapse probability after HSCT for children affected by hematologic malignancies, according to cGVHD development.

Patients experiencing cGVHD had a significantly lower risk of relapse (P = .0001).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal